| |
RC
|
RC inc. s-IgE ≥ 4.00 SU/ml
|
Allergic RC
|
Allergic RC inc s-IgE ≥ 4.00 SU/ml
|
Non-allergic RC
|
|---|
|
aOR (CI 95%)
|
aOR (CI 95%)
|
aOR (CI 95%)
|
aOR (CI 95%)
|
aOR (CI 95%)
|
|---|
|
Gender
|
1.26 (0.78–2.04)
|
1.30 (0.80–2.12)
|
1.90 (1.06–3.41)*
|
2.08 (1.14–3.81)*
|
0.64 (0.31–1.32)
|
|
FH
|
2.01 (1.25–3.23)*
|
2.01 (1.24–3.26)*
|
2.25 (1.27–3.99)*
|
2.32 (1.28–4.18)*
|
1.45 (0.72–2.92)
|
|
Early sensitization to inhalant allergens
|
1.31 (0.78–2.20)
| |
1.65 (0.91–3.02)
| |
NI
|
|
Early sensitization to foods
|
1.62 (0.99–2.67)*
| |
1.57 (0.86–2.87)
| |
NI
|
|
s-IgE ≥ 4.00 SU/ml to inhalant allergens
| |
2.03 (1.06–3.90)*
| |
2.92 (1.43–5.96)*
|
NI
|
|
s-IgE ≥ 4.00 SU/ml to food allergens
| |
2.38 (1.15–4.93)*
| |
3.13 (1.41–6.95)*
|
NI
|
|
FA
|
3.49 (1.00–12.16)
|
2.36 (0.62–8.92)
|
3.89 (1.08–14.08)*
|
2.08 (0.52–8.31)
|
NI
|
|
AD
|
2.44 (1.37–4.33)*
|
2.11 (1.17–3.81)*
|
3.24 (1.72–6.12)*
|
2.68 (1.38–5.19)*
|
NI
|
|
ETS
|
0.42 (0.26–0.69)*
|
0.42 (0.26–0.69)*
|
0.47 (0.26–0.83)*
|
0.48 (0.27–0.87)*
|
0.43 (0.20–0.92)*
|
|
Maternal tobacco smoking in pregnancy
|
NI
|
NI
|
NI
|
NI
|
0.56 (0.21–1.46)
|
|
Older siblings
|
0.64 (0.40–1.03)
|
0.66 (0.41–1.07)
|
0.53 (0.30–0.94)*
|
0.55 (0.31–1.00)
| |
-
NI not included due to univariate logistic regression analysis
- * P ≤ 0.05
